Harnessing Vδ1+ T cells for next-generation immunotherapy: from mechanistic insights to clinical translation - Top-Institutions - MDSpire

Harnessing Vδ1+ T cells for next-generation immunotherapy: from mechanistic insights to clinical translation

  • By

  • Fan Wang

  • Jiaxuan Zhao

  • Tongcun Zhang

  • Jiangzhou Shi

  • June 9, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Cancer
    • Immunotherapy

  • #2

    City of Hope National Medical Center
    City of Hope National Medical Center

    Duarte, California

    Key Differentiators

    • Cancer
    • Immunotherapy

  • #3

    The Wistar Institute
    The Wistar Institute

    Philadelphia, Pennsylvania

    Key Differentiators

    • Cancer
    • Immunology

  • #4

    Rutgers Cancer Institute of New Jersey
    Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey

    Key Differentiators

    • Cancer
    • Immunotherapy

  • #5

    Vanderbilt University
    Vanderbilt University

    Nashville, Tennessee

    Key Differentiators

    • Cancer
    • Immunotherapy

Original Source(s)

Harnessing Vδ1+ T cells for next-generation immunotherapy: from mechanistic insights to clinical translation

  • by Fan Wang, Jiaxuan Zhao, Tongcun Zhang, Jiangzhou Shi

  • June 9, 2026

Related Content

Alkaloids mediated regulation of microRNA in cancer: molecular insights and emerging therapeutic strategies

This Week’s CGT News: Promising Data for In Vivo CAR T

Legend and Kelonia reveal 100 percent response rates in phase 1 trials, dual CAR T opens doors for kidney transplant patients, and iPDSC therapy beefs up failing hearts

  • June 8, 2026

  • 6 min
Radiogenomics and the DNA damage response: opportunities for biomarker-guided radiosensitization in pancreatic cancer